Owing to more efforts exploring the utility of PD-L1 as a prognostic marker, studies demonstrated that PD-L1 expressed on tumor cells or tumor-infiltrating cells might result from separate mechanistic pathways and affect survival outcomes differently. This evidence concerns the gene CD274 and neoplasm.